Genestem Co., Ltd.
Records under this name other than patents Genestem Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Genestem Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,683,016 | PSF1-derived peptide Formerly held Lapsed on the fee record Ended Jun 20, 2025 · USPTO record | Lapsed on the fee record | Ended Jun 20, 2025 | USPTO record |
| US 10,617,750 | Partner of SLD five 1 (PSF1)-derived peptide Formerly held Lapsed on the fee record Ended Apr 14, 2024 · USPTO record | Lapsed on the fee record | Ended Apr 14, 2024 | USPTO record |
| US 9,919,039 | Partner of SLD five 1 (PSF1)-derived peptide Formerly held Lapsed on the fee record Ended Mar 20, 2022 · USPTO record | Lapsed on the fee record | Ended Mar 20, 2022 | USPTO record |